In addition to the NF-κB signaling pathway, ASTN can downregulate the c-Jun N-terminal kinase (JNK)/p-JNK signaling pathway to attenuate concanavalin A (ConA)-induced hepatitis and reduced serum liver enzymes in mice [42]. Here, NFKB1 is linked to Hepatitis.